ETA Receptor Antagonist Ameliorates Nephrosclerosis and Left Ventricular Hypertrophy Induced in Rat by Prolonged Inhibition of Nitric Oxide Synthesis.
-
- Nakamura Tetsuya
- the Second Department of Internal Medicine, Gunma University School of Medicine
-
- Kurashina Toshiaki
- the Second Department of Internal Medicine, Gunma University School of Medicine
-
- Saito Yuichiro
- the Second Department of Internal Medicine, Gunma University School of Medicine
-
- Sumino Hiroyuki
- the Second Department of Internal Medicine, Gunma University School of Medicine
-
- Akuzawa Nobuhiro
- the Second Department of Internal Medicine, Gunma University School of Medicine
-
- Aizawa Hiroki
- the Second Department of Internal Medicine, Gunma University School of Medicine
-
- Sakamoto Hironosuke
- the Second Department of Internal Medicine, Gunma University School of Medicine
-
- Ono Zenpei
- the Second Department of Internal Medicine, Gunma University School of Medicine
-
- Nagai Ryozo
- the Second Department of Internal Medicine, Gunma University School of Medicine
この論文をさがす
説明
We investigated the ability of the ETA receptor antagonist T-0115 and the angiotensin-converting enzyme (ACE) inhibitor imidapril hydrochloride to prevent hypertensive complications induced in rats by chronic inhibition of nitric oxide (NO). Male Wistar rats were given distilled water (control), NG-nitro-L-arginine methyl ester (L-NAME) 500mg/l, or L-NAME plus imidapril 10mg/l in the drinking water. In rats treated with L-NAME 500mg/l plus T-0115, T-0115 was given in the food at a dose of 0.2mg/g food or 0.6mg/g food. We then collected 24-h urine samples at 2, 4, and 6wk, obtained blood samples at 6wk, and histologically examined the kidney and heart. L-NAME markedly reduced the levels of NO metabolites in serum and urine while increasing the tail-cuff blood pressure, the urinary albumin level (1.90±0.65 vs. 0.05±0.02mg/d/100g in control), and the area of the left ventricular wall (83.3±3.0 vs. 69.8±1.8mm2 in control). The plasma renin activity was significantly higher in rats treated with L-NAME than in the control rats. The concomitant administration of T-0115 0.6mg/g food with L-NAME ameliorated the tail-cuff pressure and the albuminuria (0.56±0.23mg/d/100g), although to a lesser extent than the changes seen with imidapril 10mg/l. T-0115 0.6mg/g food prevented left ventricular hypertrophy as effectively as imidapril 10mg/l(70.8±1.8 with T-0115 vs. 68.3±2.7mm2 with imidapril). Chronic inhibition of NO synthesis produced left ventricular hypertrophy and nephrosclerosis. Our results demonstrate that inhibition of the renin-angiotensin system morely effectively prevents nephrosclerosis than does the blockade of ETA receptors in a model of hypertension induced by chronic NO blockade. However, inhibition of the ET-1 pathway appeared to be as effective as ACE inhibitors in preventing left ventricular hypertrophy in this model. (Hypertens Res 1998; 21:251-257)
収録刊行物
-
- Hypertension Research
-
Hypertension Research 21 (4), 251-257, 1998
日本高血圧学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679696432384
-
- NII論文ID
- 10009563675
- 30034931836
-
- NII書誌ID
- AA10847079
-
- COI
- 1:CAS:528:DyaK1MXksl2ntg%3D%3D
-
- ISSN
- 13484214
- 09169636
- http://id.crossref.org/issn/09169636
-
- PubMed
- 9877518
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可